Drug Farm

Drug Farm is developing innovative therapies targeting innate immunity for hepatitis B, cancer, and autoimmune diseases. Drug Farm's unique IDInVivo platform combines breakthrough technologies in genetics and artificial intelligence. The IDInVivo technology allows for the direct evaluation of gene targets in live animals with intact immune systems. Using the IDInVivo platform, Drug Farm has identified new innate immune pathways and targets and is rapidly advancing multiple first-in-class drug candidates into clinical development.